(19)
(11)EP 2 887 947 A1

(12)

(43)Date of publication:
01.07.2015 Bulletin 2015/27

(21)Application number: 13831167.5

(22)Date of filing:  22.08.2013
(51)International Patent Classification (IPC): 
A61K 31/7004(2006.01)
A61K 31/7048(2006.01)
A61P 7/00(2006.01)
A61K 31/7024(2006.01)
A61P 3/00(2006.01)
(86)International application number:
PCT/US2013/056223
(87)International publication number:
WO 2014/031875 (27.02.2014 Gazette  2014/09)
(84)Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME

(30)Priority: 23.08.2012 US 201261692567 P
03.07.2013 US 201361842671 P

(71)Applicants:
  • Seattle Genetics, Inc.
    Bothell, WA 98021 (US)
  • Regents Of The University Of Minnesota
    Minneapolis, Minnesota 55455 (US)

(72)Inventors:
  • BENJAMIN, Dennis, R.
    Bothell, Washington 98021 (US)
  • OKELEY, Nicole
    Bothell, Washington 98021 (US)
  • VERCELLOTTI, Gregory, M.
    Minneapolis, Minnesota 55455 (US)
  • BELCHER, John, D.
    Minneapolis, Minnesota 55455 (US)

(74)Representative: Carlisle, Julie 
Mewburn Ellis LLP City Tower 40 Basinghall Street
London EC2V 5DE
London EC2V 5DE (GB)

  


(54)TREATMENT OF SICKLE CELL DISEASE AND INFLAMMATORY CONDITIONS